Cytheris SA
- Country
- ๐ซ๐ทFrance
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cytheris.com
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
- First Posted Date
- 2010-11-16
- Last Posted Date
- 2013-07-25
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 92
- Registration Number
- NCT01241643
- Locations
- ๐ฟ๐ฆ
Helen Joseph Hospital-Themba Lethu Clinic, Johannesbourg, South Africa
๐จ๐ญUniversity of Zurich, Zurich, Switzerland
๐ฎ๐นSan Raffaele Scientific Institute, Milano, Italy
Study on Interleukin-7 (CYT107) in HIV Patients
- Conditions
- HIV
- Interventions
- Biological: Interleukin-7
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2013-08-01
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 23
- Registration Number
- NCT01190111
- Locations
- ๐จ๐ฆ
McGill University Health Center (MUHC), Montreal, Quebec, Canada
๐บ๐ธNiaid/Nih, Bethesda, Maryland, United States
๐บ๐ธUniversity of Miami School of Medicine, Miami, Florida, United States
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2009-12-07
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 24
- Registration Number
- NCT01027065
- Locations
- ๐ซ๐ท
Hopital Michallon, Grenoble, France
๐ซ๐ทHopital Henri Mendor-Service d'HepatoGastroEnterologie, Creteil, France
๐ซ๐ทHopital de l'Hotel Dieu, Lyon, France
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 15
- Registration Number
- NCT01024894
- Locations
- ๐จ๐ณ
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
๐จ๐ณChi Mei Medical Center, Tainan, Taiwan
๐จ๐ณCathay General Hospital, Taipe, Taiwan
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 10
- Registration Number
- NCT01025596
- Locations
- ๐จ๐ญ
University of Zurich, Zurich, Switzerland
๐ฎ๐นSan Raffaele Scientific Institute, Milano, Italy
๐ฎ๐นAzienda Ospedaliero-Universitaria, Policlinico Sant'Orsola Malpighi, Bologna, Italy
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 18
- Registration Number
- NCT01025297
- Locations
- ๐จ๐ญ
University of Zurich, Zurich, Switzerland
๐ซ๐ทHopital Jean Verdier, Bondy, France
๐ฎ๐นSan Raffaele Scientific Institute, Milano, Italy
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
- Conditions
- Kidney CancerMelanoma (Skin)
- Interventions
- Biological: recombinant interleukin-7Genetic: gene expression analysisGenetic: polymerase chain reactionGenetic: protein expression analysisOther: flow cytometryOther: immunoenzyme techniqueOther: immunologic techniqueOther: laboratory biomarker analysisOther: pharmacological study
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 9
- Registration Number
- NCT00492440
- Locations
- ๐บ๐ธ
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States
Safety Study of IL-7 in HIV-infected Patients (Inspire)
- First Posted Date
- 2007-05-23
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Cytheris SA
- Target Recruit Count
- 30
- Registration Number
- NCT00477321
- Locations
- ๐ฎ๐น
San Raffaele Scientific Institute, Milano, Italy
๐ซ๐ทHopital Henri Mendor-Service d'Immunologie Clinique, Creteil, France
๐ซ๐ทHopital Saint Louis, Paris, France